New York State Common Retirement Fund’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $55K | Hold |
12,174
| – | – | ﹤0.01% | 2913 |
|
2025
Q1 | $56K | Hold |
12,174
| – | – | ﹤0.01% | 2732 |
|
2024
Q4 | $84K | Hold |
12,174
| – | – | ﹤0.01% | 2661 |
|
2024
Q3 | $65K | Hold |
12,174
| – | – | ﹤0.01% | 2777 |
|
2024
Q2 | $46K | Buy |
12,174
+37
| +0.3% | +$140 | ﹤0.01% | 3106 |
|
2024
Q1 | $86K | Sell |
12,137
-27
| -0.2% | -$191 | ﹤0.01% | 2801 |
|
2023
Q4 | $69K | Sell |
12,164
-61
| -0.5% | -$346 | ﹤0.01% | 2888 |
|
2023
Q3 | $59K | Buy |
12,225
+75
| +0.6% | +$362 | ﹤0.01% | 2966 |
|
2023
Q2 | $83K | Sell |
12,150
-33
| -0.3% | -$225 | ﹤0.01% | 2989 |
|
2023
Q1 | $95K | Sell |
12,183
-8,165
| -40% | -$63.7K | ﹤0.01% | 2831 |
|
2022
Q4 | $155K | Sell |
20,348
-9
| -0% | -$69 | ﹤0.01% | 2831 |
|
2022
Q3 | $166K | Buy |
20,357
+59
| +0.3% | +$481 | ﹤0.01% | 2835 |
|
2022
Q2 | $196K | Buy |
20,298
+3,677
| +22% | +$35.5K | ﹤0.01% | 2810 |
|
2022
Q1 | $233K | Buy |
16,621
+9,725
| +141% | +$136K | ﹤0.01% | 2765 |
|
2021
Q4 | $141K | Buy |
6,896
+2,796
| +68% | +$57.2K | ﹤0.01% | 2987 |
|
2021
Q3 | $91K | Buy |
+4,100
| New | +$91K | ﹤0.01% | 3167 |
|